Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$310,775
+$71,319 QoQ
Shares Held
1,235
+12.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#3,599
of 4,153 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Western Financial Corp/CA holds $8,064,519 across 7 Drug Manufacturers - General names. ABBV ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
18,819 | $4,779,461 | |
| 2 | MRK |
Merck & Co., Inc.
|
5,469 | $702,766 | |
| 3 | AMGN |
Amgen Inc
|
1,902 | $688,752 | |
| 4 | LLY |
ELI LILLY & Co
|
513 | $615,307 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
4,860 | $614,012 | |
| 6 | PFE |
Pfizer Inc
|
14,678 | $353,446 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
1,235 | $310,775 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $310,775 | 1,235 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $239,456 | 1,101 | Shares | Sole | 2026-04-23 | |
| 2023-12-31 | $916,647 | 5,915 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $907,775 | 6,090 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $902,825 | 6,701 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $1,053,116 | 6,608 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,035,758 | 6,409 | Shares | Sole | 2023-01-20 | |
| No filing history on record for this holder in this stock. | ||||||